Global network of CAP accredited laboratories. Extensive test menu.
Integrated services that cover planning, management, execution and analysis.
Insight on strategies and execution for long-term value to maximise success.
Global experience in all Phases of oncology drug development.
Experience in cardiovascular trials supported by a global team of experts.
ICON has conducted diabetes trials in all global regions.
ICON and IBM are working together to revolutionise clinical trial feasibility and patient recruitment.
Designed to enhance patient engagement and support patient recruitment and retention.
Using data to design, simulate, and analyse adaptive clinical trials with ease.
Risk-adjusted, international benchmarks on health outcomes by medical condition.
The 5 things you need to know about ICH GCP (R2) 2016
Insights from ICON professionals on current clinical development issues.
ICON experts and guest speakers present on topical issues.
21 -25 MayWashington, DCICON will be speaking, exhibiting and presenting 33 scientific posters. Visit us at booth #94-95 to win a FitBit.
3 – 7 JuneMcCormick Place, ChicagoLearn about our partnerships with IBM Watson & Genomics England
16 JuneEtc.Venues St Paul's, LondonInnovation through collaboration: Bringing disruption to the patient
From a small team of 5 people in 1990, ICON now employs over 12,200 professionals in 37 countries.
We are committed to exceeding the quality standards demanded by our clients, patients and regulatory authorities.
Local knowledge combined with global expertise to ensure quality data on time and within budget.
ICON has assembled a leadership team with unrivaled vision and experience.